Catalyst Wire Dossier Catalyst Wire Dossier

FAI insert

· EyePoint Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for FAI insert, covering 2020-05-01 to 2020-07-07. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of a FAI Insert in Subjects With Chronic Non-infectious Posterior Uveitis [Phase 3]

See pricing